Consultation on the Cost-Effectiveness Methodology for Vaccination Programmes & Procurement (CEMIPP) Report

Closes 21 May 2018

Opened 26 Feb 2018


The Joint Committee on Vaccination and Immunisation (JCVI), is the independent expert committee that advises ministers on the introduction of new, and changes to existing, vaccination programmes in the UK. They asked that the methodology they use to appraise the cost–effectiveness of vaccination programmes be reviewed to see if it should differ from those used for appraising other health-related activities that use public resources.

The Cost-Effectiveness Methodology for Immunisation Programmes & Procurement (CEMIPP) group was set up as a result and reported in July 2016. A further group, the Department of Health & Social Care’s Appraisal Alignment Working Group (AAWG), set up in 2014 to consider the divergent approaches to cost-effectiveness analysis across the health and care system in England, was asked to provide a view before the CEMIPP report was published. This was received at the end of January 2018. The CEMIPP report and the AAWG’s conclusions have now been published.

Why We Are Consulting

There have been a number of calls in England to consult on the CEMIPP report from charities, the pharmaceutical industry and parliamentary committees. In view of this, we are consulting on the recommendations in the CEMIPP report. It is a complex and technical report. This consultation is therefore primarily aimed at specialists with an interest in health economics although responses from other interested parties are welcome. The consultation seeks views and further evidence to inform the Government’s decision on this report.

Give Us Your Views


  • Charities
  • Clinicians
  • Commissioners
  • Directors of Public Health
  • Providers of NHS clinical services
  • NHS Commissioning Board
  • Clinical Commissioning Groups
  • clinical staff
  • patient groups and patient advocates
  • Regulatory body
  • Academic/ Professional institution
  • Royal Colleges
  • Local authority
  • Suppliers


  • Public health
  • Immunisation
  • Funding